^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SSGJ-705

    i
    Other names: SSGJ-705, 705
    Associations

    News

    Trials
    Company:
    3SBio
    Drug class:
    PD1 inhibitor, HER2 inhibitor
    Related drugs:
    Associations

    News

    Trials
    5d
    A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients With Advanced Malignant Tumors (clinicaltrials.gov)
    P1, N=180, Recruiting, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
    New P1 trial • Metastases
    |
    SSGJ-705
    over2years
    A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Potential Anti-tumor Effects of SSGJ-705 in Patients With Advanced or Metastatic HER2-expressing Solid Tumors (clinicaltrials.gov)
    P1, N=162, Not yet recruiting, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
    Clinical • New P1 trial
    |
    HER-2 (Human epidermal growth factor receptor 2)
    |
    HER-2 expression
    |
    SSGJ-705